Skip to main content

1 Result(s)

within A. Kizhedath Remove this filter

and

  1. No Access

    Chapter

    Model-Based Risk Assessment of mAb Developability

    Monoclonal antibodies were already one of the fastest growing sectors of biopharmaceutical industry [1]. Recent research on the significant benefits of various antibodies in reducing the risks of fatality or redu...

    M. Karlberg, A. Kizhedath, J. Glassey in Optimization of Pharmaceutical Processes (2022)